This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bowles, C. T Articles by Taylor, K. M Search for Related Content PubMed PubMed Citation Articles by Bowles, C. T Articles by Taylor, K. M Social Bookmarking                         What's this?

Endotoxaemia detected during cardiopulmonary bypass with a modified Limulus amoebocyte lysate assay

Heart Science Centre, National Heart and Lung Institute at Harefield Hospital, Narefield, Middlesex

Sunil K Ohri

Cardiothoracic Unit, Department of Surgery, Hammersmith Hospital, Royal Postgraduate Medical School, London

Nongchana Klangsuk

Heart Science Centre, National Heart and Lung Institute at Harefield Hospital, Harefield, Middlesex

Bruce E Keogh

Cardiothoracic Unit, Department of Surgery, Hammersmith Hospital, Royal Postgraduate Medical School, London

Magdi H Yacoub

Heart Science Centre, National Heart and Lung Institute at Harefield Hospital, Harefield, Middlesex

Kenneth M Taylor

Cardiothoracic Unit, Department of Surgery, Hammersmith Hospital, Royal Postgraduate Medical School, London

Cardiopulmonary bypass (CPB) is associated with blood heparin level fluctuations and a reduction in haematocrit due to crystalloid haemodilution. The effect of these changes on the reliability of the Limulus amoebocyte lysate (LAL) chromogenic microassay for the measurement of plasma endotoxin was assessed in vitro. It was shown that the assay could be significantly compromised by twofold haemodilution which can occur during CPB. The interference effect on the assay caused by CPB-associated heparin was not significant if a comparatively large amount of heparin (25 IU/ml) was added to the blood at the time of sampling. The effect of haemodilution was counteracted by prediluting plasma samples with crystalloid by a factor dependent on the sample haematocrit (to ensure that the proportion of plasma was similar in all samples). A correction was then required to determine the endotoxin level in the original sample. The modified assay was used to determine sequential plasma endotoxin levels in 14 patients undergoing hypothermic nonpulsatile CPB. Endotoxaemia occurred at the time of aortic cross-clamp release and reached a peak of 48.9 ± 12.9 ng/l shortly before the end of CPB, which was significantly higher than baseline values pre-CPB (p <0.05). Thereafter, there was a decline in endotoxin levels to 28.9 ± 13.6 ng/l 24 hours later which was still significantly higher than baseline levels (p <0.05). Peak endotoxaemia was a predictor of protracted hospital stay when compared with haemodynamic and tissue perfusion parameters.

Perfusion, Vol. 10, No. 4, 219-228 (1995)
DOI: 10.1177/026765919501000404


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. K Ohri and T. Velissaris Gastrointestinal Dysfunction Following Cardiac Surgery Perfusion, July 1, 2006; 21(4): 215 - 223. [PDF]

				V. Videm, J. L Svennevig, E. Fosse, B. Mohr, and A. O Aasen Plasma endotoxin concentrations during cardiac surgery may be related to atherosclerosis Perfusion, September 1, 2000; 15(5): 421 - 426. [Abstract] [PDF]

				S. K Ohri Systemic inflammatory response and the splanchnic bed in cardiopulmonary bypass Perfusion, May 1, 1996; 11(3): 200 - 212. [PDF]